person

Tu-Anh D.

Country
France
Department
Dermatologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
15
Sites with multiple studies

Has run more than one trial at 15 of 28 partner sites.

Specializations

Dermatology and Inflammatory Skin Disease

Clinical research includes atopic dermatitis, psoriasis, hidradenitis suppurativa, vitiligo, prurigo nodularis, and bullous pemphigoid, with additional interest in cutaneous lupus erythematosus, pemphigus, and severe cutaneous squamous cell carcinoma.

  • Atopic dermatitis
  • Psoriasis and psoriatic arthritis
  • Hidradenitis suppurativa
  • Vitiligo and prurigo nodularis
  • Autoimmune blistering skin disease

Work at Assistance Publique Hôpitaux de Paris, Hôpital Ambroise Paré, and Hôpital Beaujon connects dermatologic care with immune-mediated and oncologic skin conditions.

Autoimmune and Systemic Inflammatory Disease

Research activity spans systemic lupus erythematosus, lupus nephritis, Sjögren’s disease, ANCA-associated vasculitis, giant cell arteritis, systemic sclerosis, and idiopathic inflammatory myopathies, alongside rheumatoid arthritis and psoriatic arthritis.

  • Systemic lupus erythematosus and lupus nephritis
  • Sjögren’s disease
  • ANCA-associated vasculitis
  • Systemic sclerosis
  • Idiopathic inflammatory myopathies

Therapeutic interests also include IgG4-related disease, cryoglobulinemic vasculitis, polymyalgia rheumatica, and other chronic immune-mediated disorders requiring long-term disease control.

Oncology and Cutaneous Cancer

The investigator is involved in studies of cutaneous squamous cell carcinoma, melanoma, basal cell carcinoma, head and neck squamous cell carcinoma, and broader solid tumors, with attention to advanced and recurrent disease settings.

  • Cutaneous squamous cell carcinoma
  • Melanoma
  • Head and neck squamous cell carcinoma
  • Advanced solid tumors
  • Skin cancer

Research also extends to non-small cell lung cancer, gastrointestinal cancers, and hepatocellular carcinoma, reflecting a strong interest in oncology-linked therapeutic innovation.

Inflammatory Bowel and Digestive Disease

Clinical trial involvement includes Crohn’s disease, ulcerative colitis, inflammatory bowel disease, and short bowel syndrome, together with liver-related disorders such as primary sclerosing cholangitis and metabolic dysfunction-associated steatohepatitis.

  • Crohn’s disease
  • Ulcerative colitis
  • Inflammatory bowel disease
  • Primary sclerosing cholangitis
  • Metabolic liver disease

Additional interest covers hepatocellular carcinoma, cirrhosis, and portal hypertension, supporting a digestive-disease portfolio that overlaps with hepatology.

Renal, Vascular, and Cardiopulmonary Disease

Research spans chronic kidney disease, IgA nephropathy, membranous nephropathy, focal segmental glomerulosclerosis, kidney transplant rejection, and acute kidney injury, alongside cardiovascular disease, heart failure, myocardial infarction, and stroke.

  • Chronic kidney disease and glomerular disease
  • Kidney transplant rejection
  • Heart failure and myocardial infarction
  • Stroke and thromboembolic disease
  • Pulmonary hypertension and interstitial lung disease

Interest also includes pulmonary arterial hypertension, idiopathic pulmonary fibrosis, and sepsis-related organ dysfunction, indicating engagement with complex multisystem therapeutic areas.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.